Canada
Study aims to prove safety of psilocybe mushrooms so Canadian regulators can expand access to psychedelic therapy
Hi, what are you looking for?
Study aims to prove safety of psilocybe mushrooms so Canadian regulators can expand access to psychedelic therapy
The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine
Pairing the psychedelic substance with a serotonin blocker could greatly expand its clinical use, according to new research from the University of Pittsburgh.
New research suggests that magic mushrooms can enhance your ability to spontaneously generate creative insights
Australia is funding research to see if magic mushrooms and ecstasy can treat depression and PTSD
A recent review suggests natural settings and activities can complement all stages of psychedelic-assisted therapy
The Washington State-based biotech startup's application covers a range of cannabinoids and psilocybin compounds
Proposed by Health Canada, the change would allow patients to access restricted substances like MDMA through the Special Access Program
With major research, legal reform, and more than 20 firms going public, it was major year for the re-emerging field
After raising $8.1M, the Calgary company filed 12 patents and launched a candidate selection program for novel psychedelic mental health treatments
